Psychedelic Therapy For Pregnant & Breastfeeding Mothers Ft. Mikaela de la Myco

Rematriating Psychedelics

In all of Mikaela’s work, the overarching goal is clear: to rematriate the world of psychedelics. The word “rematriate” quite literally means “to return to the Sacred Mother,” and specifically refers to repairing the relationship between indigenous cultures and their ancestral lands.

“Remember where you come from; we come from land and we come from our moms. Protecting both is vital and important and should be centered in the psychedelic community.” — Mikaela de la Myco

In De la Myco’s sphere of work, its modern lens is geared toward restoring the rights, responsibilities, respect and resources of women, including mothers, maternal caretakers, and any one who’s work centers around children. 

The question then becomes: how does that look in our society today?

The Glaring Absence of Women in Psychedelic Research

The western research model has notoriously neglected women, as many studies in the early 20th century either don’t have female participants, don’t account for the differences between genders, or neglected to put any effort into researching women’s bodies or their cycles.

According to Eagly et al. (2012), research into the psychology of women only began after the feminist movement of the 1960’s, peaking in the 1970’s and 2000’s, but Mikaela de la Myco points out it isn’t nearly as comprehensive as it should be. 

This is especially true for the intersection of psychedelics and topics like menstruation, pregnancy and breastfeeding.

“A lot of the issues we deal with in the larger schema of the world, whether that’s rape culture or sexual assault or violations, or just postpartum depression, those things we’re seeing in the bigger space, in our culture, is very much present here in our smaller psychedelic community. So if we can heal it here and work things out in the smaller level, maybe we can start to expand that out and build models for what we do in the larger space.” — Mikaela de la Myco

Mothers of the Mushroom Research

After publishing a 52-page ebook that comprises the cultural and scientific information regarding entheogens (ayahuasca, cannabis, peyote, psilocybin-containing mushrooms, LSD etc.) and their impact on pregnancy, breastfeeding and postpartum, De la Myco decided to deep dive into a more specific topic.  

De la Myco’s Mothers of the Mushroom research initiative surveyed over 400 participants who had engaged in psilocybin-containing mushrooms either during pregnancy, breastfeeding, or postpartum. 

This research project asked participants detailed questions about their lived experiences with the medicine, both qualitative and quantitative. 

It was inspired by the work that she did with Dr. James Fadiman, who wished to include a chapter about pregnancy, breastfeeding and postpartum in his book on microdosing, health, healing and performance. 

Together, they built the survey and were able to synthesize the data they collected from 411 participants. 

200 of the participants had already had a relationship with psilocybin before pregnancy, which is a common find in De la Myco’s research.

She reports that it’s common for people who have had a relationship with psilocybin to then question how it fits into their life as a new mother. 

If psilocybin has helped them through so much, and they are now entering the new phase of life that is motherhood, how does their relationship with it change? Do they need to stop? Will it harm their child?

These are common enough questions that they absolutely warrant research, so, what did they find? Well, of the 411 participants, 237 ingested psilocybin while breastfeeding and 178 ingested psilocybin while pregnant. There wasn’t a single fatality reported within that population. 

That might not seem like a major breakthrough, but it actually is when you realize the absolute lack of scientific data surrounding topics like motherhood and psychedelics. 

We now have scientific data to show that there is no causal relationship between psilocybin and infant mortality. 

Most participants (~95%) had either had a psilocybin prior to pregnancy, or started postpartum. That is to say that only a small percentage began their psilocybin journey while pregnant, but it’s still important to represent this population.

The most common use phase was after giving birth, with some mothers starting psilocybin 1-3 years after birth.

Having this data allowed them, without control of any other variables, to compare psilocybin pregnancies against national averages like birth weight and length. 

While it was a small cohort study, “all reported newborns were healthy at birth, with no significant deviations from population norms in weight, length, or overall condition.”

This information opens up even more questions and research avenues to explore, such as longitudinal studies of the children that were born from mothers who ingested psilocybin at some point during pregnancy or breastfeeding. 

The survey also collected data on topics like motivations, outcomes, challenges, which allows more informed guidelines and care for those who choose to bring psilocybin into motherhood. 

De la Myco found that a common reason mothers turn to psychedelics is to combat symptoms from long-standing and prevalent problems among new mothers, like postpartum depression. 

Perinatal depression, which is an umbrella term for depressive symptoms while pregnant or within a year after childbirth, affects approximately 1 in 7 people yet it’s believed that 50% of cases are left undiagnosed, whether it be from lack of accessible healthcare or stigmas making new mothers reluctant to seek help (Mughal et al., 2024).

“This is a huge population of people that are dealing with anxiety, long-term difficulty bonding, sadness, in a very critical time where the next generation is really being set up and the foundation of that generation is crumbling. So just to consider, post-traumatic depression is a public health concern.” —Mikaela de la Myco

De la Myco’s research reveals that oftentimes, mothers are in fact receiving the benefits they sought psilocybin out for in the first place.

Especially those who are seeking alternatives to pharmaceuticals, which was a popular motivation reported in the study because many pharmaceuticals prescribed for postpartum depression don’t have studies to back their long-term safety. 

The Mothers of the Mushroom research found that many participants reported significant relief from anxiety and depression, it was easier to manage overwhelming emotions, less burdened by intrusive thoughts, and consequently they were able to connect with their loved ones better. 

This is a major breakthrough for the nearly 3 million mothers in the US that suffer from peri or postpartum depression.

Salient Research Points from Mothers of the Mushroom

When asked what mothers found challenging about their experiences with psilocybin and motherhood, there were a few common themes and were typically dose-dependent. 

There were some physiological challenges, including nausea, sleepiness, or irritability, which isn’t dissimilar to normal psilocybin experiences. 

Finding the right dose and the right container were the most common challenges reported.

In some cases, microdoses ended up being more powerful than desired, which can pose a challenge when trying to care for not only yourself, but your child as well. 

For one, it can resurface trauma and result in a clash of responsibilities when your child needs lunch but you really just want to cry in bed. From these reports, we know how important it is to set your dose and set your container.

The second most common negative symptom was the feelings of paranoia and guilt from internalizing the stigma of ingesting psychedelics as a mom. 

“That guilt was actually showing up a lot for some of these moms, like, ‘I have crippling depression and I need help because I don’t even want to live anymore. I can’t change a diaper because I can’t move. And this one thing that might be able to help me, I feel bad about trying’, you know?”

In some cases the guilt can be so overwhelming it actually blocks out any positive benefits they were seeking in the first place. 

“Where did this all come from? Did the drug war and the crack mom like propaganda machine really like fall on everyone when there’s t-shirts that say ‘don’t talk to me, I haven’t had my coffee.’” — Mikaela de la Myco

Another positive data point that arose from De la Myco’s research is that the most common dosing amongst mothers was microdosing. It goes further than consumption though, as a lot of mothers are also facilitators, cultivators, and tackling policy reform. 

The survey also dove into how it affects the children of the mothers choosing to have a relationship with psilocybin, and the most common benefit was that by moms using psilocybin to better themselves, they in turn become better moms. 

This finding adds another layer to the research, it’s not just a conversation about blood-brain barriers and children getting doses of psilocybin through breastfeeding, which is the biggest public concern regarding this topic. 

It’s also about how children can benefit by being in close proximity to the healing that psilocybin mushrooms are providing, especially to mothers. 

“That’s the greatest benefit we’re seeing and that’s what the mothers are reporting is they’re now organizing and constructing their lives, what they’re eating, what kinds of media they watch, what kinds of schools these kids go to because of the insights that they experience with mushrooms.” — Mikaela de la Myco

De la Myco looks forward to the future where she will be able to ask the children from this survey what it was like to grow up in their homes. 

She’ll be able to use the Adverse Childhood Experiences Questionnaire (ACE), first created in 1998 with now over 2 decades of research, to compare how mothers and their kids’ childhoods differed.

After all, “adverse childhood experiences and rearing may cause a public health burden that could rival or exceed all other root causes” (Zarse et al., 2019). 

If future research continues to show a positive correlation between mothers who partake in psilocybin and happy childhoods for their children, it would be a revolutionary finding. 

This is especially true considering Galán et al. (2025) just published a study that suggests an adverse childhood environment (measured by parental discipline tactics) has a “modest but significant role” in shaping dark personality traits (narcissism, machiavellianism, psychopathy). 

Ethical Considerations to Psilocybin Research & Motherhood

Just a few years ago, De la Myco was having door slammed in her face for even trying to conduct psilocybin and motherhood research, but unfortunately there hasn’t been any significant findings for conventional interventions that are effective or without unwanted side effects. 

Survey-based research and citizen science was then the first option to begin research of this kind for a few reasons.

Firstly, in order to receive funding for a study to investigate postpartum depression and psilocybin, synthetic psilocin or synthetic psilocybin would need to be used, which doesn’t model typical use and would only act as a way for the company to legitimize their synthetic product. 

The second reason is that the study would require moms to stop breastfeeding, which is a natural process that has a myriad of benefits, especially for the maternal-fetal connection. 

Conventional research would require losing some of the components that are imperative to the goal of this research, which includes the whole psilocybin-containing mushroom, and breastfeeding.

De la Myco’s research model closely follows that of Dr. Fadiman. The idea is to find those who are engaging in the research topic in their everyday life, and to use their lived experiences as a data set.

“That’s been his methodology and I was very inspired by that because it kind of works around those issues and at least gets us to a point where we can get a preliminary understanding for how humans are engaging. And that’s the point of this kind of research is humans are engaging in fact and whether or not there is stigma, there aren’t legal protections. The reason we don’t have research is partially because of its federal status. We needed to anonymize this. We needed to make sure that people’s stories were protected but still had a space for compassionate inquiry.” — Mikaela de la Myco

The Importance of an Informed Perspective

There is a paper trail of research that helped De la Myco come to the conclusion that there is an ethical component to producing a study exploring the relationship between moms and psilocybin.

Thanks to Law et al. (2014), we know that after intravenous injection of c-psilocin, psilocin (the metabolized form of psilocybin) did pass through the placental and blood-brain barriers of pregnant rats, with c-psilocin levels being much lower in fetuses than mothers. 

However, we know that psilocybin is one of the two classic psychedelics, mescaline being the other, that has the highest safety profile when considering death as a toxic endpoint.

A systematic review of psychedelic toxicity by Henríquez-Hernández et al. (2023) came to the conclusion that,

 “In some cases, a 100-fold increase in the effective dose does not cause harmful effects on the health of individuals, which defies the basic principle of toxicology. Perhaps with the exception of MDMA, historically reported deaths do not appear to be the sole responsibility of the substance, but rather related to the environment and circumstances of intake.”

If you were to compare the toxicity of psilocybin by milligrams, with death being the toxic endpoint, against substances like caffeine, nicotine or aspirin, psilocybin ends up being safer. 

De la Myco has also learned through her connection with indigenous cultures that there has been acceptance of psilocybin use during pregnancy among some of these cultures for millenia.

Recommended Reading: The Intimate Relationship Between Humans & Psychedelics

Bridging Indigenous Wisdom and Western Society

The Mothers of the Mushroom Project seeks to bring indigenous wisdom into western society in a way that is palatable for the mainstream. Remember America’s history? The flower children of the 60s and 70s? 

Mothers in indigenous and western societies alike have been partaking in psychedelics for generations, it’s about time we explore what’s already out there. 

In fact, there are researchers in Columbia who are treating postpartum depression with psilocybin-containing mushrooms as we speak. 

Interestingly enough, a narrative review done by Jairaj & Rucker (2022) compares the symptoms of postpartum depression with the effects of psilocybin and reports that there is strong evidence to suggest efficacy of psychedelic-assisted therapy, with serotonergics such as psilocybin, as a successful treatment for postpartum depression (PPD). 

The review also explores safety considerations, research history of PPD and how current treatment falls short, as well as psilocybin research as it relates to generalized depression, which is generally how researchers find new treatments for PPD.

It’s almost a disservice to ourselves to shy away from doing the kind of research that makes western societies uncomfortable, when it’s been so fruitful for other cultures. 

What can help bridge this gap? Reading the transformative and emotional stories of the 411 participants’ lived experiences with psilocybin and motherhood. 

Getting this information to those who it relates to most, is also a very important aspect of bridging traditional knowledge with conventional science and western societal norms. 

The irony in all this is that Western individualistic societies shy away from generational knowledge at all costs. When we look at indigenous cultures we find they are teeming with generational knowledge. Mushrooms are common to find in the medicine cabinet, along with many other medicinal plants.

They can go to their aunt, uncle, mom or grandmother for guidance. There are protocols in place that are supported by a whole community. This is much different than hiding in your room for 12 hours so your family doesn’t find out about your psychedelic use.

It’s also true for communal support, not just guidance about plant medicine. Becoming a new mom is a major life transition where bringing a new life into the world has you questioning your identity and values, and people need support as they work through these transitory periods. 

Recommended Reading: Psychedelics for Womanhood, Fertility, & Menopause Ft. Mikaela de la Myco

Differences in Beliefs About Breastfeeding

This difference in cultures is exemplified in the most polarized part of this conversation: breastfeeding. 

In Western society, we are so concerned about exposing our children to psilocybin through breastmilk that we’ll do anything to avoid it.

In the Mazatec community, it couldn’t be more different. One family shared that introducing children to psilocybin through breastfeeding, is the exact filtration system needed to safely introduce them to the substance. 

Not in our western society though, if you skim through WebMD’s updated list (as of 2023) of what prescription medications, over the counter medications, supplements and herbs to avoid while pregnant, you’ll find confusing results. 

Many substances, like acetaminophen and some antidepressants readily pass through the placental barrier, reaching the fetus, but that doesn’t stop WebMD from telling you they’re fine to take while pregnant. 

Per the stigma that permeates the US, when it comes to psilocybin, the conversation will often go something like, “under no circumstances should your baby be exposed to it during pregnancy or breastfeeding.” 

How can that be when preliminary research shows no reports of fetal death, developmental delays or significant change in birth weight?

Especially when we look at the bar set for prescribed and over the counter medication. A direct quote from WebMD’s Pain Relievers That Are Safe During Pregnancy article states that, 

“Most pregnant women can take acetaminophen if their doctor gives them the thumbs-up. It’s the most common pain reliever that doctors allow pregnant women to take. Some studies have found that about two-thirds of pregnant women in the U.S. take acetaminophen sometime during their nine-month stretch…

…Some research suggests that taking acetaminophen daily for long periods (28 days or longer) could put your baby at greater risk of mild developmental delays or attention deficit hyperactivity disorder (ADHD).

Other research has shown that taking acetaminophen daily, or almost daily, during the second half of your pregnancy increases your baby’s odds of wheezing or having asthma.

None of the research proves that acetaminophen causes these problems and further studies are necessary to understand the link.”

So, let me get this straight. Psilocybin is safer than caffeine, nicotine and aspirin, and hasn’t shown any of the negative fetal effects that prescribed or over the counter medications have shown? So why is mainstream society so against it?

It probably has something to do with the firm hold that pharmaceutical companies have on the United States legislature and healthcare system, but that’s not for us to say. Today we are here to celebrate the powerful research being done from the ground up. 

Going Beyond Familial Units

Dulas, midwives, doctors and therapists should all be aware of the research being done so that they can be informed when more mothers start to open up about their experiences with psilocybin and motherhood. 

At a Harvard University panel in 2023 to discuss psychedelic therapy for veterans, Former CDC Director Rochelle Walensky stated, “We know in the medical community that once a new, novel methodology or method is reported in the literature, it can take 17 years to reach the community and we don’t have that kind of time.”

With the medical industry and politics often being “behind the times” in relation to the societies they’re in, it’s up to citizen science to do the research while formal processes catch up.

What Does The Future Hold?

To appease the scientific appetite of our Western society and do their due diligence, De la Myco is excited to announce that she’s working with researcher Tess Burzynski, who is researching psilocybin breast milk, and the results of the study will be posted on De la Myco’s website. 

Burzynski is taking samples of breast milk from mothers who’ve taken a variety of doses, and testing it in a lab to collect as much data as possible. This data includes looking at the half-life of psilocybin, and how much actually gets transferred to breast milk. 

De la Myco is hopeful for the future, and sees a world where mental health options are protected, not weaponized. 

She ends the interview reminding us to think of the impact a generation of children who grew up with well-adjusted adults can make on the future. 

Imagine just for a minute, that the Stoned Ape Theory was proven to be true. That as we came down from the trees and into the fields thousands of years ago, we were inadvertently introduced to the “magic mushroom” and it changed the course of our evolution forever. 

Think of the early hominid encountering psilocybin mushrooms, and generation after generation ingesting them. What would that do for human development and cooperation?

Is it a coincidence that within the Stoned Ape Theory, Terence Mckenna talks about the development of linguistic centers in the brain, empathy, and collaboration, and mothers in De la Myco’s research are unpromptedly reporting advanced development in these same areas in their children?

While Terence theorized a lot about how psilocybin mushrooms could have affected the hunting class, he doesn’t discuss the gatherers much. That is, the gestators; the mothers and grandmothers raising the future generations. 

So as we come to a close, remember that the mechanism for evolution will always be birth. A conversation about evolution cannot be had without birth, or without looking at how changes in mothers’ epigenetics through psychedelic use will be passed down to their children.

Interestingly, studies are just beginning to roll out that investigate how therapeutic psychedelic experiences change our DNA. A 2023 pilot study done by Lewis et al., does show promising results that warrant new research.

From where we stand, the future is brimming with possibilities. We are slowly but surely seeing psychedelic medicine represented in research and education, politics, legislature, and therapeutic modalities in a way reminiscent of the 60’s, but so much more powerful.

As we navigate this evolving landscape of psychedelic research and its implications for mental health and human development, it becomes increasingly clear that we are on the cusp of a transformative era. 

By fostering an understanding of how substances like psilocybin can influence not only individual well-being but also societal progress, we are opening up discussions that could reshape our values around healing, connection, and parenting.

In the spirit of progress, we must also recognize our responsibility to ensure that the benefits of these discoveries are accessible to all, creating a more equitable landscape for mental wellness. 

As we continue to explore the profound effects of psychedelics, let us remain committed to learning, growing, and nurturing a better world for present and future generations. 

Together, we can manifest a reality where the extraordinary potential of the human experience is fully realized, paving the way for a brighter, more harmonious tomorrow.

How You Can Contribute

Mikaela de la Myco and her research team are dedicated to this research long-term, and are very interested in conducting longitudinal studies to explore the relationship between mothers, their children, and psilocybin. 

Do you have a story to share? Tell your story and help shape the narrative surrounding psilocybin and pregnancy, breastfeeding, and postpartum. Women and birthing people of all gender expressions are encouraged to submit.

This research is crowd-sourced, with a GoFundMe that has been completely funding the project. So, if you feel like this education is important and benefits you in whatever role you serve, click the link below to donate and find out more. 

De la Myco reminds us that this journey is bigger than research, it extends into our familial systems, our communities, larger societies, permeating every aspect of life. It’s about lived experiences and practices, and working towards global well-being.

More From Our Guest

• Visit Mothers of the Mushroom for the full research paper, including more data and statistics.
• Check out MushWomb for personalized consultations and resources.
• Support the Mothers of the Mushroom research initiative by contributing to or sharing their GoFundMe campaign.

Tell Your Mom You Love Her Today

They are the gentle hands that guide us, the voices that uplift us, and the hearts that nurture our souls. And to all the incredible moms out there, this is your reminder: you are deserving of all the love and appreciation you give so freely.

• Get A More In Depth Look at Intergenerational Trauma: Come with us as we delve into the transformative journey of Sutton King in addressing the trauma in her Indigenous communities.
• Nothing Can Replace Self-Love: Self-love isn’t just about caring for your physical needs, it’s something that everyone struggles with, but everyone deserves.
• The Dynamic Relationship Between SSRIs & Psilocybin: Somewhere between the fear mongering and the psychedelic diehards lies the truth about these two substances and how they interact.
• Thank You For Our Privacy Dr. Blei! Ethical concerns are of the utmost importance in scientific research, learn more about why they are important in psychedelic medicine as well.
• Involving Friends or Family: Discover how to ask for support, and the pros and cons to having a friend or family member, or even a pet attend your ceremony.
• Not Sure How to Approach Your Doctor?: Not everyone will talk to their primary care doctor about intentional psychedelic use, but if you should need to, we have compiled all you need to know to feel confident moving forward. 
• Privilege, Accessibility & Ethical Responsibility: See for yourself how living your truth can mean many different things, but that there are parallels hidden in each unique story where we can all find common ground.  
• Find The Value in Anecdotes: Still not sure what you’re getting yourself into? Check out other’s stories to get a better idea on how magic mushrooms make you feel.

Speak With a Trusted Psychedelic Coach Today

Hi there! We sincerely hope that you’ve found valuable takeaways that resonate with your current intentions. To explore research-based education, stay updated with psychedelic news, and benefit from practical how-to articles, we encourage you to head over to our resources page.

If you’re seeking personalized advice and are prepared to take the first step toward a therapeutic psychedelic experience, we invite you to book a consultation with our team of experienced psychedelic concierges.

This consultation is more than just a conversation; it’s an opportunity to be matched with a trustworthy local facilitator. You’ll be seamlessly connected to our rigorously vetted network of psychedelic guides, ensuring potential matches align with your needs.

Psychedelic Passage offers confidence and peace of mind by alleviating the burden of having to guess who’s right for you. If you want to discover how Psychedelic Passage can help you, we empower you to learn more about our services and check out client testimonials from those who’ve gone before you.

Your healing path is uniquely yours, and our commitment is to serve you at every juncture. Psychedelic Passage: Your Psychedelic Concierge — The easy, legal way to find trustworthy psilocybin guides, facilitators and psychedelic assisted therapy near you in the United States.

Learn More About Our Network

• Book a Consultation Call
• Meet Our Referral Network
• Explore Frequently Asked Questions
• Watch Client Testimonials
• Is Psychedelic Passage Safe & Legit?

More Psychedelic Passage

• Listen to our podcast on Spotify, Apple Podcasts, and iHeartRadio
• Subscribe to our Youtube Channel
• Follow us on Instagram, Reddit, Twitter, and Linked in for bite-sized updates and content.

Frequently Asked Questions

1. What is the “Mothers of the Mushroom” research initiative and what are its main goals?

The “Mothers of the Mushroom” research initiative aims to explore the connections between psilocybin use and motherhood. 

By surveying over 400 mothers who engaged with psilocybin during pregnancy, breastfeeding, or postpartum, the research seeks to collect both qualitative and quantitative data to highlight the potential benefits, safety profiles, and challenges of using psilocybin in maternal contexts. 

The overarching goal is to empower women, reduce stigma surrounding psychedelic use, and reclaim indigenous wisdom in mental health practices.

2. How does Mikaela de la Myco define “rematriation” in relation to psychedelics?

Rematriation refers to the process of restoring the rights, responsibilities, respect, and resources of women, including mothers and maternal caretakers, in the psychedelic community. 

It emphasizes the need to return to “the Sacred Mother” and repair relationships between indigenous cultures and their ancestral practices. In de la Myco’s work, rematriation seeks to center women’s experiences and healing in the psychedelic movement.

3. What are some of the common benefits and challenges reported by mothers using psilocybin during pregnancy and postpartum?

Many mothers reported benefits such as alleviation of symptoms related to postpartum depression, improved mental well-being, and enhanced parenting abilities. 

Challenges included physiological side effects, feelings of guilt and paranoia due to societal stigma about psychedelic use, and the struggle to find an appropriate dosing strategy that allows them to care for themselves and their children simultaneously.

4. Why is there a lack of research on the effects of psychedelics on women, particularly in relation to motherhood?

Historically, the western research model has neglected women, often excluding them from studies or failing to account for gender differences. 

This gap in research has particularly impacted the fields of psychedelics, menstruation, pregnancy, and breastfeeding, creating a significant need for studies like de la Myco’s that focus specifically on women’s experiences with these substances.

5. What ethical considerations arise from conducting research on psilocybin use among mothers?

Ethical considerations include the need to ensure the safety of both mothers and children in research settings. Implications of using synthetic psilocybin versus whole mushrooms is one example. 

There is also a need to protect participants’ identities and lived experiences, especially in a legal environment that may stigmatize such substances. de la Myco emphasizes the importance of citizen science and the collection of personal narratives to navigate these ethical dilemmas.

6. How can the findings from this research impact the future of maternal mental health care?

The results from the “Mothers of the Mushroom” research can contribute to developing informed guidelines for using psilocybin in maternal healthcare. 

By providing data that supports the safety and potential benefits of psilocybin, the research can influence policy changes, encourage mental health professionals to adopt more holistic treatment options, and ultimately transform the conversation around maternal mental health and the use of psychedelics in healing practices.

References

Eagly, A. H., Eaton, A., Rose, S. M., Riger, S., & McHugh, M. C. (2012). Feminism and psychology: Analysis of a half-century of research on women and gender. American Psychologist, 67(3), 211–230. https://doi.org/10.1037/a0027260

Galán, M., Pineda, D., Rico-Bordera, P., Piqueras, J. A., & Muris, P. (2025). Dark childhood, dark personality: Relations between experiences of child abuse and dark tetrad traits. Personality and Individual Differences, 238, 113089. https://doi.org/10.1016/j.paid.2025.113089

Henríquez-Hernández, L. A., Rojas-Hernández, J., Quintana-Hernández, D. J., & Borkel, L. F. (2023). Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?—A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines. Toxics, 11(2), 148. https://doi.org/10.3390/toxics11020148

Jairaj, C., & Rucker, J. J. (2022). Postpartum depression: A role for psychedelics? Journal of Psychopharmacology, 36(8), 026988112210937. https://doi.org/10.1177/02698811221093793

Law, F., Poon, G., Chui, Y., & He, S.-X. (2014). Functional Foods in Health and Disease, 4(6), 232–246. https://www.functionalfoodscenter.net/files/91110287.pdf

Lewis, C. R., Tafur, J., Spencer, S., Green, J. M., Harrison, C., Kelmendi, B., Rabin, D. M., Yehuda, R., Yazar-Klosinski, B., & Cahn, B. R. (2023). Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.959590

Mughal, S., Azhar, Y., Siddiqui, W., & Carlson, K. (2024). Postpartum depression. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK519070/

Zarse, E. M., Neff, M. R., Yoder, R., Hulvershorn, L., Chambers, J. E., & Chambers, R. A. (2019). The adverse childhood experiences questionnaire: two decades of research on childhood trauma as a primary cause of adult mental illness, addiction, and medical diseases. Cogent Medicine, 6(1). https://doi.org/10.1080/2331205x.2019.1581447